These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 11224850)

  • 21. [Visceral childhood leishmaniasis: diagnosis and treatment].
    Prieto Tato LM; La Orden Izquierdo E; Guillén Martín S; Salcedo Lobato E; García Esteban C; García-Bermejo I; Ramos Amador JT
    An Pediatr (Barc); 2010 May; 72(5):347-51. PubMed ID: 20378427
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Historical series of patients with visceral leishmaniasis treated with meglumine antimoniate in a hospital for tropical diseases, Maceió-AL, Brazil.
    Silveira LJ; Rocha TJ; Ribeiro SA; Pedrosa CM
    Rev Inst Med Trop Sao Paulo; 2015; 57(1):33-8. PubMed ID: 25651324
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiologic surveillance of visceral leishmaniasis in Sicily, Italy.
    Cascio A; Gradoni L; Scarlata F; Gramiccia M; Giordano S; Russo R; Scalone A; Camma C; Titone L
    Am J Trop Med Hyg; 1997 Jul; 57(1):75-8. PubMed ID: 9242323
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low dosage combination of meglumine antimoniate plus allopurinol as first choice treatment of infantile visceral leishmaniasis in Italy.
    di Martino L; Mantovani MP; Gradoni L; Gramiccia M; Guandalini S
    Trans R Soc Trop Med Hyg; 1990; 84(4):534-5. PubMed ID: 2091347
    [No Abstract]   [Full Text] [Related]  

  • 25. Splenic granulomatous lesions in immunocompetent pediatric patients with visceral leishmaniasis.
    Fretzayas A; Moustaki M; Kitsiou S; Mathioudakis J; Karpathios T
    Scand J Infect Dis; 2001; 33(11):865-7. PubMed ID: 11760174
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful treatment of visceral leishmaniasis with allopurinol plus ketoconazole in an infant who developed pancreatitis caused by meglumine antimoniate.
    Kuyucu N; Kara C; Bakirtaç A; Teziç T
    Pediatr Infect Dis J; 2001 Apr; 20(4):455-7. PubMed ID: 11332679
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The renal transplant patient with visceral leishmaniasis who could not tolerate meglumine antimoniate-cure with ketoconazole and allopurinol.
    Hueso M; Bover J; Serón D; Gil-Vernet S; Rufí G; Alsina J; Grinyó JM
    Nephrol Dial Transplant; 1999 Dec; 14(12):2941-3. PubMed ID: 10570102
    [No Abstract]   [Full Text] [Related]  

  • 28. Glucantime-resistant visceral leishmaniasis in immunocompromised patients.
    Verdejo J; Alvar J; Polo RM; González-Lahoz JM
    Am J Med; 1988 Jul; 85(1):128. PubMed ID: 3389377
    [No Abstract]   [Full Text] [Related]  

  • 29. Severe leucopenia during treatment of visceral leishmaniasis.
    Hiçsönmez G; Jama H; Ozsoylu S
    Trans R Soc Trop Med Hyg; 1988; 82(3):417. PubMed ID: 3232176
    [No Abstract]   [Full Text] [Related]  

  • 30. A 7-month-old girl with fever and bleeding.
    Chaliasos N; Bourantas C; Kritikou E; Lapatsanis P
    Lancet; 1996 Apr; 347(9008):1086. PubMed ID: 8602061
    [No Abstract]   [Full Text] [Related]  

  • 31. [Association of acute lymphoblastic leukaemia and visceral leishmaniasis].
    Nafil H; Tazi I; Mahmal L
    Ann Biol Clin (Paris); 2011; 69(6):729-31. PubMed ID: 22123576
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An 8-Year Retrospective Study of Human Visceral Leishmaniasis.
    Barbosa JF; de Figueiredo SM; Lyon S; Caligiorne RB
    Curr Clin Pharmacol; 2016; 11(4):265-269. PubMed ID: 27659611
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Visceral leishmaniasis in infants without bioptic demonstration of the parasite. Presentation of 3 cases].
    Cataldo F; Violante M; Bellia L; Traverso MG; Albeggiani A
    Pediatr Med Chir; 1989; 11(1):81-4. PubMed ID: 2717490
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Childhood visceral leishmaniasis in Muzaffarabad, Azad Jammu and Kashmir: frequency and response to treatment in 61 cases.
    Altaf C; Ahmed P; Ashraf T; Anwar M; Ahmed I
    J Pak Med Assoc; 2005 Nov; 55(11):475-8. PubMed ID: 16304865
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prolonged Th2 cell activation and increased viral replication in HIV-Leishmania co-infected patients despite treatment.
    Cacopardo B; Nigro L; Preiser W; Famá A; Satariano MI; Braner J; Celesia BM; Weber B; Russo R; Doerr HW
    Trans R Soc Trop Med Hyg; 1996; 90(4):434-5. PubMed ID: 8882199
    [No Abstract]   [Full Text] [Related]  

  • 36. Efficacy of aminosidine administered alone or in combination with meglumine antimoniate for the treatment of experimental visceral leishmaniasis caused by Leishmania infantum.
    Gangneux JP; Sulahian A; Garin YJ; Derouin F
    J Antimicrob Chemother; 1997 Aug; 40(2):287-9. PubMed ID: 9301998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of kala azar.
    Ozsoylu S
    Lancet; 1996 Jun; 347(9016):1701. PubMed ID: 8642997
    [No Abstract]   [Full Text] [Related]  

  • 38. Pediatric visceral leishmaniasis in Western Sicily, Italy: a retrospective analysis of 111 cases.
    Cascio A; Colomba C; Antinori S; Orobello M; Paterson D; Titone L
    Eur J Clin Microbiol Infect Dis; 2002 Apr; 21(4):277-82. PubMed ID: 12072938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pseudo-acute transformation of an idiopathic myelofibrosis due to kala-azar.
    Disdier P; Swiader L; Serratrice J; Mary C; Weiller PJ
    Br J Haematol; 1998 Feb; 100(2):449. PubMed ID: 9488642
    [No Abstract]   [Full Text] [Related]  

  • 40. Visceral leishmaniasis and renal tuberculosis in a patient on maintenance haemodialysis.
    Peces R; de la Torre M; Alcázar R
    Nephrol Dial Transplant; 1996 Apr; 11(4):707-8. PubMed ID: 8671866
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.